Home > Insider Trading > Filing (0001213900-20-024785)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1522602	Cohbar Inc.	CWBR	Pharmaceutical Preparations (2834)	261299952

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1791221	Misha Petkevich	C/O Cohbar, Inc. 1455 Adams Drive, Suite 2050 Menlo Park CA 94025		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-08-28	204,918	$0.00	223,609	No	4	P	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	See Footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Warrants (right to buy)	Acquisiton	2020-08-28	153,688	$0.00	153,688	$1.44

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
153,688	2020-08-28	2025-08-28	No	4	P	Indirect

Footnotes

The reported securities are included within Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of the Issuer's common stock and one warrant to purchase 0.75 of one share of the Issuer's common stock at an exercise price of $1.44 per share.
The Reporting Person is a General Partner of V2M Life Sciences L.P. ("V2M"), and has sole voting and dispositive power over the securities held by V2M. The Reporting Person disclaims beneficial ownership over such securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.